Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

So far, only two confirmed cases involving this specific recombinant virus have been documented through full genomic sequencing: - One case occurred in the United Kingdom in December 2025, involving a ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The detection of a newly identified recombinant mpox virus containing genetic material from two known strains underscores the need for continued genomic surveillance, the UN World Health Organization ...

Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases. Studies have shown that it can help reduce damage and inflammation, ...

The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Researchers in France have reported the first compelling genetic evidence of a recombinant SARS-CoV-2 virus that contains elements of both the omicron coronavirus variant and the delta variant.

LYON, France--(BUSINESS WIRE)--BioNet Europe, the French subsidiary of BioNet, a vaccine manufacturer specializing in the development of genetically engineered vaccines, has announced the submission ...

Please provide your email address to receive an email when new articles are posted on . Recombinant herpes zoster vaccine recipients had lower risk for developing dementia compared with those who ...